Skip to main content

Published locations for ASCO advises against PARP inhibitor retreatment in ovarian cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASCO advises against PARP inhibitor retreatment in ovarian cancer

User login

  • Reset your password
  • /content/asco-advises-against-parp-inhibitor-retreatment-ovarian-cancer
  • /fedprac/article/230792/gynecologic-cancer/asco-advises-against-parp-inhibitor-retreatment-ovarian
  • /oncologypractice/article/230792/gynecologic-cancer/asco-advises-against-parp-inhibitor-retreatment
  • /fedprac/avaho/article/230792/gynecologic-cancer/asco-advises-against-parp-inhibitor-retreatment
  • /hematology-oncology/article/230792/gynecologic-cancer/asco-advises-against-parp-inhibitor